A detailed history of Chesapeake Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Chesapeake Asset Management LLC holds 9,158 shares of LLY stock, worth $9.36 Million. This represents 8.14% of its overall portfolio holdings.

Number of Shares
9,158
Previous 8,868 3.27%
Holding current value
$9.36 Million
Previous $6.77 Million 38.28%
% of portfolio
8.14%
Previous 6.31%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026

BUY
$799.57 - $1025.28 $231,875 - $297,331
290 Added 3.27%
9,158 $9.36 Million
Q3 2025

Oct 17, 2025

SELL
$625.65 - $812.69 $19,395 - $25,193
-31 Reduced 0.35%
8,868 $6.77 Million
Q2 2025

Oct 15, 2025

BUY
$713.71 - $898.95 $6.35 Million - $8 Million
8,899 New
8,899 $6.94 Million
Q1 2025

Jan 05, 2026

BUY
$725.72 - $929.72 $56,606 - $72,518
78 Added 0.88%
8,936 $7.38 Billion
Q4 2024

Jan 05, 2026

SELL
$727.2 - $932.06 $533,764 - $684,132
-734 Reduced 7.65%
8,858 $6.84 Billion
Q3 2024

Jan 05, 2026

BUY
$772.14 - $960.02 $20,847 - $25,920
27 Added 0.28%
9,592 $8.5 Billion
Q2 2024

Jan 05, 2026

BUY
$724.87 - $909.04 $505,234 - $633,600
697 Added 7.86%
9,565 $8.66 Billion
Q1 2024

Jan 05, 2026

SELL
$592.2 - $792.28 $466,061 - $623,524
-787 Reduced 7.6%
9,573 $7.45 Billion
Q4 2023

Jan 05, 2026

BUY
$525.19 - $619.13 $51,468 - $60,674
98 Added 0.95%
10,360 $6.04 Billion
Q3 2023

Jan 05, 2026

BUY
$434.7 - $599.3 $89,982 - $124,055
207 Added 2.06%
10,262 $5.51 Billion
Q2 2023

Jan 05, 2026

SELL
$350.74 - $468.98 $397,388 - $531,354
-1,133 Reduced 10.13%
10,055 $4.72 Billion
Q1 2023

Jan 05, 2026

BUY
$310.63 - $364.82 $720,661 - $846,382
2,320 Added 26.16%
11,188 $3.84 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Chesapeake Asset Management LLC Portfolio

Follow Chesapeake Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Asset Management LLC with notifications on news.